ABL1
Advances in Cancer Research Volume 85. Advances in Cancer Research. 85. (2002). 51–100. doi:10.1016/S0065-230X(02)85003-5. ISBN 978-0120066858. PMID 12374288
“Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature”. Cancer Genet. Cytogenet. 138 (2): 139–42. (2002). doi:10.1016/S0165-4608(02)00609-X. PMID 12505259.
“Abl: the prototype of oncogenic fusion proteins”. Cell. Mol. Life Sci. 61 (23): 2897–911.
ABL1の発現がmiR-203(英語版)によって調節されている証拠も得られている。
(2004). doi:10.1007/s00018-004-4271-0. PMID 15583852.
“Role of c-Abl in the DNA damage stress response”. Cell Res. 15 (1): 33–5. (2005). doi:10.1038/sj.cr.7290261. PMID 15686624.
“Regulation for nuclear targeting of the Abl tyrosine kinase in response to DNA damage”. Advances in Molecular Oncology. Advances in Experimental Medicine and Biology. 604. Springer. (2007). 155–65. doi:10.1007/978-0-387-69116-9_15. ISBN 978-0-387-69114-5. PMID 17695727. https://archive.org/details/advancesinmolecu00inte/page/155